MetaADEDB 2.0 @ LMMD
Betamethasone Valerate
(SNHRLVCMMWUAJD-SUYDQAKGSA-N)
Structure
SMILES
CCCCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F)C(=O)CO
Molecular Formula:
C27H37FO6
Molecular Weight:
476.577
Log P:
3.6368
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
100.9
CAS Number(s):
2152-44-5
Synonym(s)
1.
Betamethasone Valerate
2.
Betamethasone 17-Valerate
3.
Flubenisolonvalerate
4.
Betnovate
5.
17-Valerate, Betamethasone
6.
Betamethasone 17 Valerate
7.
Valerate, Betamethasone
External Link(s)
MeSHD001624
PubChem Compound16533
ChEBI31277
CHEMBLCHEMBL1497
DrugCentral354
KEGGdr:D01357
Therapeutic Target DatabaseD03SXE
ZINC3882052
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 13US FAERS
2Application site painFAERS: 8US FAERS
3AlopeciaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
4Inappropriate schedule of drug administrationFAERS: 6US FAERS
5ErythemaFAERS: 5OFFSIDES
US FAERS
6PruritusFAERS: 517827870CTD
US FAERS
7HypersensitivityFAERS: 4US FAERS
8Product quality issueFAERS: 4US FAERS
9Accidental exposureFAERS: 3US FAERS
10AcneFAERS: 3US FAERS
11Burning sensationFAERS: 3US FAERS
12Dry skinFAERS: 3US FAERS
13HeadacheFAERS: 3US FAERS
14PainFAERS: 3US FAERS
15Product physical consistency issueFAERS: 3US FAERS
16Skin irritationFAERS: 3US FAERS
17Wrong technique in product usage processFAERS: 3US FAERS
18Accidental exposure to productFAERS: 2US FAERS
19Application site erythemaFAERS: 2US FAERS
20BlindnessFAERS: 2US FAERS
21Cataract operationFAERS: 2US FAERS
22CataractFAERS: 2US FAERS
23DizzinessFAERS: 2US FAERS
24Drug DependenceFAERS: 2US FAERS
25Drug withdrawal syndromeFAERS: 2US FAERS
26Expired product administeredFAERS: 2US FAERS
27Eye irritationFAERS: 2US FAERS
28GlaucomaFAERS: 2US FAERS
29Intentional drug misuseFAERS: 2OFFSIDES
US FAERS
30Abdominal discomfortFAERS: 1US FAERS
31Adverse eventFAERS: 1OFFSIDES
US FAERS
32AnxietyFAERS: 1OFFSIDES
US FAERS
33Application site noduleFAERS: 1US FAERS
34Application site swellingFAERS: 1US FAERS
35AsphyxiaFAERS: 1US FAERS
36AsthmaFAERS: 1US FAERS
37Blood cholesterol increasedFAERS: 1US FAERS
38Body temperature fluctuationFAERS: 1US FAERS
39Cerebrovascular accidentFAERS: 1US FAERS
40ChemotherapyFAERS: 1US FAERS
41ChillsFAERS: 1US FAERS
42ConstipationFAERS: 1US FAERS
43DermatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Drug administered at inappropriate siteFAERS: 1US FAERS
45Drug ineffective for unapproved indicationFAERS: 1US FAERS
46DysgeusiaFAERS: 1OFFSIDES
US FAERS
47Eczema HerpeticumFAERS: 1US FAERS
48EczemaFAERS: 1US FAERS
49EpistaxisFAERS: 1US FAERS
50Expired drug administeredFAERS: 1US FAERS
51Eye painFAERS: 1OFFSIDES
US FAERS
52FatigueFAERS: 1OFFSIDES
US FAERS
53Feeling ColdFAERS: 1US FAERS
54Genital rashFAERS: 1US FAERS
55ImmobileFAERS: 1US FAERS
56Incorrect drug administration durationFAERS: 1US FAERS
57Incorrect route of drug administrationFAERS: 1US FAERS
58LymphadenopathyFAERS: 1US FAERS
59MalaiseFAERS: 1US FAERS
60Pain of skinFAERS: 1US FAERS
61Product administered at inappropriate siteFAERS: 1US FAERS
62Product label issueFAERS: 1US FAERS
63Product physical issueFAERS: 1US FAERS
64Product prescribing errorFAERS: 1US FAERS
65Product substitution issueFAERS: 1US FAERS
66PsoriasisFAERS: 1OFFSIDES
US FAERS
67Pustular psoriasisFAERS: 1OFFSIDES
US FAERS
68Rebound effectFAERS: 1US FAERS
69Red man syndromeFAERS: 1US FAERS
70RosaceaFAERS: 14231359CTD
US FAERS
71ScabFAERS: 1US FAERS
72Secretion dischargeFAERS: 1US FAERS
73Skin UlcerFAERS: 1US FAERS
74SwellingFAERS: 1US FAERS
75Therapy non-responderFAERS: 1OFFSIDES
US FAERS
76VitiligoFAERS: 1US FAERS
77Weight decreasedFAERS: 1US FAERS
78ActinomycosisOFFSIDES
79AlveolitisOFFSIDES
80AmphetaminesOFFSIDES
81AngioedemaOFFSIDES
82AnhedoniaOFFSIDES
83AnorexiaOFFSIDES
84Anoxic EncephalopathyOFFSIDES
85Aspiration PneumoniaOFFSIDES
86Bacteria urine identifiedOFFSIDES
87Blood glucose decreasedOFFSIDES
88Blood potassium increasedOFFSIDES
89Bone painOFFSIDES
90BronchopneumoniaOFFSIDES
91BruxismOFFSIDES
92CellulitisOFFSIDES
93Cerebral ThrombosisOFFSIDES
94Chest PainOFFSIDES
95Chronic ulcerative colitisOFFSIDES
96Cleft PalateOFFSIDES
97Deafness NeurosensoryOFFSIDES
98DeafnessOFFSIDES
99DebridementOFFSIDES
100Dental cariesOFFSIDES
101Depressed moodOFFSIDES
102Dermatitis, Atopic15940147CTD
103DiabetesOFFSIDES
104Diabetic NephropathyOFFSIDES
105Drug Eruptions4278287CTD
106Drug addictOFFSIDES
107Drug exposure during pregnancyOFFSIDES
108EctropionOFFSIDES
109Emotional distressOFFSIDES
110Erythema MultiformeOFFSIDES
111Erythrodermic psoriasisOFFSIDES
112FibromyalgiaOFFSIDES
113Fistula repairOFFSIDES
114Fixed eruptionOFFSIDES
115GastroenteritisOFFSIDES
116Gastrointestinal ulcerOFFSIDES
117GranulocytosisOFFSIDES
118HistologyOFFSIDES
119HyperkeratosisOFFSIDES
120ImpetigoOFFSIDES
121Implant site cellulitisOFFSIDES
122Infectious MononucleosisOFFSIDES
123Intestinal ObstructionOFFSIDES
124LeukoencephalopathyOFFSIDES
125Liver AbscessOFFSIDES
126Lung InjuryOFFSIDES
127Lymphocytic infiltrationOFFSIDES
128MacrocytosisOFFSIDES
129Malignant melanoma in situOFFSIDES
130Molluscum ContagiosumOFFSIDES
131NasopharyngitisOFFSIDES
132NoduleOFFSIDES
133Oral Cavity FistulaOFFSIDES
134OsteomyelitisOFFSIDES
135PO2 decreasedOFFSIDES
136PallorOFFSIDES
137PapillomaOFFSIDES
138Pharyngolaryngeal PainOFFSIDES
139Pleural InfectionOFFSIDES
140PneumothoraxOFFSIDES
141Primary sequestrumOFFSIDES
142Purulent dischargeOFFSIDES
143Respiratory tract congestionOFFSIDES
144SnoringOFFSIDES
145Steroid withdrawal syndromeOFFSIDES
146Subcutaneous AbscessOFFSIDES
147T-Cell LymphomaOFFSIDES
148Telangiectasis952530
4231359
CTD
149Tooth ExtractionOFFSIDES
150Tooth InfectionOFFSIDES
151Tooth LossOFFSIDES
152Toxic anterior segment syndromeOFFSIDES
153Unevaluable eventOFFSIDES
154Unresponsive to stimuliOFFSIDES
155Urine ketone body absentOFFSIDES
156UrticariaCanada Vigilance: 1Canada Vigilance
157Zinc deficiencyOFFSIDES
158kyphosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.